Cardiology Research Institute, Tomsk National Research Medical Center, Tomsk.
Kardiologiia. 2021 Jul 31;61(7):14-21. doi: 10.18087/cardio.2021.7.n1420.
Aim To evaluate the predictive value of indexes of left ventricular mechanical dyssynchrony (MD) as determined by data of electrocardiogram (ECG)-gated myocardial perfusion scintigraphy (ECG-MPS) for prediction of the efficacy of resynchronization therapy (RT) in patients with chronic heart failure (CHF).Material and methods This prospective study included 32 patients with nonischemic CHF and standard indications for RT. All patients underwent complete clinical an instrumental examination, including 24-h ECG monitoring and echocardiography (EchoCG). In order to evaluate the left ventricular (LV) myocardial perfusion, contractile function, and MD, myocardial perfusion scintigraphy was performed for all patients at rest prior to RT. In addition to the perfusion defect size at rest and hemodynamic parameters, LV MD was determined. The following indexes were used for analysis of dyssynchronization: phase standard deviation (PSD), phase histogram bandwidth (HBW), and phase histogram asymmetry and steepness. The treatment efficacy was evaluated by the clinical status of patients (clinical condition evaluation scale for CHF patient) and EchoCG at 6 months following RT. The criteria for a positive response to RT were an increase in LV ejection fraction (EF) by 5% and/or a decrease in the LV end-diastolic volume by 15% compared to preoperative values.Results According to ECG-MPS findings, all patients had scintigraphic signs of severe CHF with dilated LV cavity (end-diastolic volume, EDV 246 [217; 269] ml) and also of pronounced mechanical and electrical dyssynchrony. The values of mechanical dyssynchrony were PSD 53 [41; 61], HBW 176 [136; 202], asymmetry 1.62 [1.21; 1.89], and steepness 2.81 [1.21; 3.49]. The QRS duration was 165 [155; 175] msec. Furthermore, the LV perfusion was moderately impaired (perfusion defect size 4 [3; 10] %). Mean follow-up duration after implantation of the resynchronizing device was 6±1.7 mos. According to the selected criteria, 20 (63 %) patients were considered as responders and 12 (37 %) patients as non-responders. Before implantation of the cardiac synchronizing device, responders and non-responders differed only in LV MD (PSD 44 [35; 54] vs. 63 [58; 72]; p=0.0001); HBW 158 [118; 179] vs. 205 [199; 249]; p=0.0001; asymmetry 1.77 [1.62; 2.02] vs. 1.21 [0.93; 1.31]; p=0.0001; steepness 3.03 [2.60; 3.58] vs. 1.21 [0.19; 1.46]; p=0.0001), respectively. A one-factor logistic regression analysis showed that MD values were statistically significant predictors of a positive response to RT. A multi-factor logistic analysis of phase histogram steepness (odds ratio, OR 1.196; 95 % confidence interval, CI 1.04-1.37) and PSD (OR 0.67; 95 % CI 0.47-0.97) were identified as independent predictors for the response to RT. According to results of the ROC analysis, a PSD <55 and a phase histogram steepness >1.54 may predict the effectiveness of RT (AUC= 0.92; р=0.0001).Conclusion LV MD parameters determined with ECG-MPS allow predicting the effectiveness of RT in patients with nonischemic CHF. In this patient group, high values of standard deviation and low values of phase histogram steepness were independent predictors for the absence of response to RT after 6 mos. of follow-up.
目的 评估心电图门控心肌灌注显像(ECG-MPS)左心室机械不同步(MD)指数预测慢性心力衰竭(CHF)患者心脏再同步化治疗(RT)疗效的价值。
材料与方法 前瞻性研究纳入 32 例非缺血性 CHF 且符合 RT 标准适应证的患者。所有患者均接受了完整的临床和仪器检查,包括 24 小时心电图监测和超声心动图(EchoCG)。为了评估左心室(LV)心肌灌注、收缩功能和 MD,所有患者在 RT 前进行了静息心肌灌注显像。除了静息时的灌注缺损大小和血流动力学参数外,还确定了 LV MD。用于分析不同步的指标包括相位标准差(PSD)、相位直方图带宽(HBW)和相位直方图不对称性和陡度。通过 RT 后 6 个月的患者临床状况(CHF 患者临床状况评估量表)和 EchoCG 评估治疗效果。RT 反应阳性的标准为 LV 射血分数(EF)增加 5%,或 LV 舒张末期容积减少 15%,与术前相比。
结果 根据 ECG-MPS 结果,所有患者均有严重 CHF 的闪烁征象,包括左心室腔扩张(舒张末期容积 246[217;269]ml)和明显的机械和电不同步。机械不同步的数值为 PSD 53[41;61]、HBW 176[136;202]、不对称性 1.62[1.21;1.89]和陡度 2.81[1.21;3.49]。QRS 持续时间为 165[155;175]ms。此外,LV 灌注中度受损(灌注缺损大小 4[3;10]%)。心脏再同步化装置植入后平均随访时间为 6±1.7 个月。根据所选标准,20(63%)例患者被认为是有反应者,12(37%)例患者为无反应者。在植入心脏同步装置之前,有反应者和无反应者仅在 LV MD 方面存在差异(PSD 44[35;54]与 63[58;72];p=0.0001);HBW 158[118;179]与 205[199;249];p=0.0001;不对称性 1.77[1.62;2.02]与 1.21[0.93;1.31];p=0.0001;陡度 3.03[2.60;3.58]与 1.21[0.19;1.46];p=0.0001)。单因素逻辑回归分析显示,MD 值是 RT 反应的统计学显著预测因子。相位直方图陡度(优势比,OR 1.196;95%置信区间,CI 1.04-1.37)和 PSD(OR 0.67;95%CI 0.47-0.97)的多因素逻辑分析被确定为 RT 反应的独立预测因子。根据 ROC 分析结果,PSD <55 和相位直方图陡度 >1.54 可能预测 RT 的有效性(AUC=0.92;p=0.0001)。
结论 心电图门控心肌灌注显像测定的 LV MD 参数可预测非缺血性 CHF 患者 RT 的疗效。在该患者组中,PSD 较高和相位直方图陡度较低是 RT 后 6 个月无反应的独立预测因子。